— The Danish drugmaker stock added 5.5% after saying late Tuesday it was halting Ozempic's kidney disease treatment trial after a committee said an analysis showed signs of success.— Shares of dialysis services providers DaVita and Fresenius Medical Care sank 18.4% and 19.6%, respectively, on Novo Nordisk's news. Baxter International, which makes products for chronic dialysis therapies, slid 9%.shale rival Pioneer Natural Resources for $59.
The No. 1 thing CEOs are investing in right now, says a new survey—you can use it to get a lucrative jobthat Japanese companies will invest $1 billion in Coherent's silicon carbide business. On Wednesday, B. Riley upgraded shares to buy from neutral, saying Coherent's silicon carbide business could be worth more than the Street's current estimate.— The battery company climbed 3.
مصر أحدث الأخبار, مصر عناوين
Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.
مصدر: nbcchicago - 🏆 545. / 51 اقرأ أكثر »
مصدر: NBCNewYork - 🏆 270. / 63 اقرأ أكثر »
مصدر: CNBC - 🏆 12. / 72 اقرأ أكثر »